Analysis of Global Policies on Generic Medicines

Access to generic medicines plays a critical role in reducing healthcare costs and ensuring the availability of essential medications for the population. This article reviews global policies, regulations, and approaches that promote the distribution of generics across different countries, as well as the barriers to their circulation, such as stringent regulatory frameworks, negative public perceptions, and market dynamics. Using Georgia as a case study, the analysis examines local regulations aimed at increasing competition by encouraging the use of generic medicines and reducing their prices. The cost advantage of generics enhances their competitiveness and accessibility for consumers. Support from healthcare professionals, raising public awareness, and refining state regulations contribute to the rational use of medicines. Considering these factors, the article highlights the necessary measures required at both global and local levels to improve the accessibility of generic medicines and optimize healthcare expenditures. Keywords: Bioequivalence, Drug affordability, Generic medicines, Healthcare costs, Pharmaceutical market.